S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KRBP Kiromic BioPharma Inc

0.60

0.00 (0.00%)

Last Updated: 18:00:00

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Kiromic BioPharma (NASDAQ:KRBP)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Kiromic BioPharma Charts.

Kiromic BioPharma (NASDAQ:KRBP)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Kiromic BioPharma Charts.

Kiromic BioPharma Inc News

Kiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Thursday 19 September 2024 (4 months ago) • Business Wire

Kiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous Recommendation
Thursday 19 September 2024 (4 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 21 August 2024 (5 months ago) • Edgar (US Regulatory)

Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation
Wednesday 14 August 2024 (5 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 9 August 2024 (5 months ago) • Edgar (US Regulatory)

Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial
Friday 9 August 2024 (5 months ago) • Business Wire

Kiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01
Thursday 1 August 2024 (5 months ago) • Business Wire

Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase
Thursday 18 July 2024 (6 months ago) • Business Wire

Form 8-K - Current report
Friday 28 June 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 June 2024 (7 months ago) • Edgar (US Regulatory)

Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial
Thursday 20 June 2024 (7 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 June 2024 (7 months ago) • Edgar (US Regulatory)

More Kiromic BioPharma Inc News Articles

Code Green Apparel (PK)

Virexit Technologies (PK)

UAV Corpoation (PK)

Saddle Ranch Media (PK)

Digital Brand Media and ... (PK)

KULR Technology

Bioelectronics (PK)

Liquidmetal Technologies (QB)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions